First Affiliated Hospital Of Guangxi Medical University
Clinical trials sponsored by First Affiliated Hospital Of Guangxi Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a stem cell spray stop radiation mouth pain? Results expected Jun 2027 (estimated)
-
Could a common stroke drug help patients over 80?
Disease control Recruiting nowThis study is testing whether the clot-busting drug tenecteplase is safe and effective for people aged 80 and older who have had a stroke. Researchers will track 392 patients to see how well they recover and if there are any serious side effects. The goal is to find out if this t…
Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New combo therapy aims to improve survival in advanced nose cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new drug (Becotatug vedotin) plus immunotherapy (sintilimab) and standard chemoradiation works better than current standard treatment for high-risk nasopharyngeal cancer. About 266 adults with advanced but non-spread cancer will be randomly assi…
Phase 3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New eye test criteria could speed up diagnosis of vision loss cause
Diagnosis Recruiting nowThis study looks at whether a new set of international criteria can accurately diagnose optic neuritis—a condition that causes sudden vision loss—in Chinese patients. Researchers will enroll 500 people with acute or subacute vision loss and compare the criteria's results against …
Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC